Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 9.24-25.6820.5517.58-18.84

What is the latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS is 9.24 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar20249.24
Mar2023-25.68
Mar202220.55
Mar202117.58
Mar2020-18.84

How is Core EBITDA Growth of AAREY DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 9.24
Positive
Mar2023 -25.68
Negative
Mar2022 20.55
16.89
Mar2021 17.58
Positive
Mar2020 -18.84 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹157.7 Cr 2% -0% 23% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,614.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,533.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,439.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹110,076.0 Cr -2.3% 8.2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,066.0 Cr 1.4% -1.5% 13.3% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

2%

-0%

23%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses